In ₹ Crore except Per Share Latest Annual	INDOKEM FY26	AMAL FY26	ARCL FY25	CHEMCRUX FY26	Peer Average
Valuation — at last close
P/E	835.45×	19.35×	◆ 14.56×	—	16.96× +4827%
P/B	32.18×	◆ 0.88×	2.26×	—	1.57× +1947%
EV/EBITDA	787.96×	—	◆ 8.14×	—	8.14× +9580%
Market Cap	₹1,780 Cr	₹87.8 Cr	₹171 Cr	—	₹129 Cr +1275%
Growth
Revenue CAGR 3Y	9.24%	◆ 29.43%	—	-4.61%	12.41% -26%
Revenue CAGR 5Y	10.56%	◆ 22.79%	—	—	22.79% -54%
Net Income CAGR 3Y	-9.04%	◆ 83.96%	—	-68.48%	7.74% -217%
Profitability
EBITDA Margin	1.55%	9.59%	9.48%	◆ 12.38%	10.48% -85%
Net Income Margin	1.44%	◆ 5.35%	4.69%	0.54%	3.53% -59%
Return on Common Equity	3.93%	4.64%	◆ 15.53%	—	10.08% -61%
Return on Capital Employed	2.87%	6.39%	◆ 18.49%	—	12.44% -77%
Return on Assets	1.61%	4.01%	◆ 7.30%	2.54%	4.62% -65%
Credit & Quality
Total Debt/Equity	0.48×	—	◆ 0.46×	—	0.46× +4%
Interest Coverage	0.67×	◆ 10.06×	3.81×	6.01×	6.63× -90%
Scale — latest FY
Revenue / Total Income	₹148 Cr	₹84.9 Cr	₹251 Cr	₹82.6 Cr	₹139 Cr +6%
Net Income	₹2.1 Cr	₹4.5 Cr	₹11.8 Cr	₹0.4 Cr	₹5.6 Cr -62%
Total Assets	₹134 Cr	₹117 Cr	₹161 Cr	₹17.7 Cr	₹98.5 Cr +36%
EPS	₹0.77	₹28.9	₹14.69	—	₹21.79 -96%
Book Value per Share	₹19.99	₹633.73	₹94.57	—	₹364.15 -95%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.